Staar Surgical Co

STAANASDAQ · USD
26.39USD0.00 (-1.46%)
577

Staar Surgical Co (STAA) Option Chain

Staar Surgical Co trades at $26.39, down 1.46%, with an IV Rank of 29.76%. This is low versus the past year, and the company carries a market cap of $1,325M in the Medical Instruments & Supplies industry. On the Nov 20, 2026 chain, the at the money $27.50 strike shows calls at $0.20 / $0.55 and puts at $1.20 / $2.60, both carrying about $0.58 of extrinsic value and a roughly 50% probability of expiring out of the money. Volume is heaviest on the $27.50 calls, at 21 contracts, and the $17.50 puts, at 1, as of Nov 13, 2026.

Read more

Tracking the STAA option chain helps you see every strike and expiry on Staar Surgical Co in one view, so you can quickly identify contracts that fit your thesis and your risk. It lays out bids, asks, volume, open interest, and Greeks across calls and puts, giving you the full map of STAA options activity at a glance. Use our scanner to monitor the STAA option chain in real time and filter for the trades that actually meet your criteria.

An option chain is the complete listing of all available option contracts on an underlying, organized by expiration date and strike price. For STAA stock options, the chain shows call and put data side by side, making it easy to compare premiums, assess liquidity, and spot pricing dislocations. Reading it well means looking beyond the last price. Implied volatility by strike, volume to open interest ratios, and bid ask spreads all show where STAA options are being actively traded, and where they are not.

STAAR Surgical Company, together with its subsidiaries, designs, develops, manufactures, markets, and sells implantable lenses for the eye, and companion delivery systems to deliver the lenses into the eye. The company provides Visian implantable Collamer lens product family (ICLs) to treat visual disorders, such as myopia, hyperopia, astigmatism, and presbyopia; and Hyperopic ICL, which treats far-sightedness. It also offers preloaded silicone cataract intraocular lenses and injector systems for use in cataract surgery. In addition, the company sells injector parts, and other related instruments and devices.

2026-11-20
5 strikes
Default
CALLsPUTs
Prob. OTM %Open InterestVolumeExtrinsic ValueIntrinsic ValueBidAskStrikeMoneyness %BidAskIntrinsic ValueExtrinsic ValueVolumeOpen InterestProb. OTM %
1.887900.663.893.205.9022.50-14.74—0.250.000.2503198.12
24.6123110.311.391.451.9525.00-5.27—0.500.000.5003175.39
71.63262210.380.000.200.5527.50+4.211.202.601.110.790528.37
95.7432510.130.000.050.2030.00+13.681.904.403.61-0.46004.26
99.732100.950.00—0.9532.50+23.154.106.806.11-0.66000.27

As of Nov 13, 2026

Prices move. This one stays.Lock in 5 years at a special price and save $2,243. Ending soon.See the Early Bird Black Friday deal →

Stock Statistics

  • IndustryMedical Instruments & Supplies
  • SectorHealthcare
  • IV Rank29.76% Low
  • Market cap (M$)1,325
  • 52 weeks high-26.43%
  • 52 weeks low69.38%
  • Analyst recommendationHold
    2.60
  • Target price$29.25
    10.84% above the current stock price
  • Dividend—
  • Payout ratio—
  • Earnings date2026-11-04
  • P/E—
  • Future P/E45.12
  • EPS (ttm)0.00
  • EPS growth next 5 years—

As of Nov 13, 2026